Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 20, 2014
Pharmacy Choice - Pharmacy News - August 20, 2014

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
8/19/14 - Eli Lilly: FDA Grants Tentative Approval For Insulin Drug Basaglar
INDIANAPOLIS- Eli Lilly and Co said Monday the U.S. Food and Drug Administration granted tentative approval for Basaglar, which is indicated to improve glycemic control in adults with type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with type 1 diabetes. Basaglar is Eli Lilly and Boehringer Ingelheim's basal
8/19/14 - FDA Approves Genzymeâ??s Cerdelgaâ?¢ (eliglustat) Capsules
Genzyme, a Sanofi company, announced today that the U.S. Food and Drug Administration has approved Cerdelgaâ?¢ capsules, the only first-line oral therapy for certain adult Gaucher disease type 1 patients. â??Cerdelga is an important new option for people living with Gaucher disease type 1,â?? said Rhonda Buyers, CEO of the National Gaucher Foundati
8/19/14 - FDA approves new drug for rare genetic disease
Cerdelga is from Genzyme, the specialty drugmaker that introduced the first drug for Gaucher's disease 20 years ago. The oral treatment could serve as an alternative to Genzyme's best-selling drug Cerezyme, which is given intravenously. Genzyme says it will soon release pricing for its new drug.
8/19/14 - FDA Approves Use of AFLURIA® Influenza Vaccine with PharmaJetâ??s Needle-Free Injector
KING OF PRUSSIA, Pa.& GOLDEN, Colo.---- PharmaJet ® Inc., the developer of a needle-free injection technology to administer medications and vaccines to patients, and bioCSL Inc., the maker of AFLURIA ® today announced the U.S. Food and Drug Administration has approved the PharmaJet Stratis ® 0.5 mL Needle-Free Jet Injector for delivery of AFLURI
8/19/14 - FDA Grants Tentative Approval For Lilly And Boehringer Ingelheim's Basaglar
INDIANAPOLIS- Eli Lilly and Co. and Boehringer Ingelheim said Monday that the U.S. Food and Drug Administration has granted tentative approval for Basaglar, or insulin glargine injection, which is indicated to improve glycemic control in adults with type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with type
8/19/14 - Genzyme Receives FDA Approval For Cerdelga Capsules
PARIS- Genzyme, a Sanofi company announced that it has received approval from the U.S. Food and Drug Administration or FDA for its Cerdelga capsules, the only first-line oral therapy for certain adult Gaucher disease type 1 patients. Genzyme has been researching an oral therapy for Gaucher disease for fifteen years, from early chemistry and preclin

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Lupus: What You Need to Know
This lesson is supported by:
RxSchool
West Virginia Best Practice Prescribing & Drug Diversion Training
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415